Loading clinical trials...
Loading clinical trials...
Brachial plexus block is used for upper limb surgery. Local anesthesia alone for brachial plexus block provides good operative conditions, but have short duration of postoperative analgesia. Hence, various adjuvants to local anaesthetic agents to prolong the duration of peripheral nerve, analgesia. However, results are either inconclusive or associated with side effects. The purpose of this study is to determine whether dexmedetomidine as an adjuvant to ropivacaine in brachial plexus block improve quality of block in terms of duration of post operative analgesia.
Age
20 - 60 years
Sex
ALL
Healthy Volunteers
No
Nepal medical college
Kathmandu, Bagmati, Nepal
Start Date
February 1, 2023
Primary Completion Date
July 30, 2023
Completion Date
August 30, 2024
Last Updated
September 4, 2024
40
ACTUAL participants
ropivacaine, lidocaine with adrenaline
DRUG
Dexmedetomidine, ropivacaine, lidocaine with adrenaline
DRUG
Lead Sponsor
Nepal Medical College and Teaching Hospital
NCT07475975
NCT04917536
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions